Today talk, page-24

Thanks for that, poloker. I had come across CRISPR a few times in my rounds of the net but had yet to look into it properly. The following is one of the better short vids on the subject. Given that CRISPR is a DNA or gene editor (in simplistic terms), it suggests that the technology could lead to cures in lifelong inherited diseases which some cancers are (but not all). The info on the net indicates that whilst a number of companies have the technology and appear to be moving closer to commercialisation, they are essentially still in development stage and there's the potential risk for unfamiliar adverse events associated with this novel modality of therapy, apparently. And, there appears to be all sorts of wrangles too over the IP. However, the fact is that there is a lot of innovative technologies and therapies out there which I'm sure Prescient is abreast of and looking into for ways of harnessing or complimenting our own innovations.